文献速递妇科

小体积FIGO IB1期宫颈癌的保守手术方法:扩大队列的生存与产科结局更新

Conservative surgical approaches for small volume FIGO stage IB1 cervical cancer. Updated survival and obstetric outcomes of an expanded cohort.
PubMed 文献 · Gynecol Oncol · 2023-08-03

研究纳入2000年12月至2021年12月在北方妇科肿瘤中心治疗的117例FIGO IB1期、环切标本估计肿瘤体积<500 mm3的宫颈癌患者,58例(49.5%)行LLETZ保留生育功能,59例(50.5%)行单纯子宫切除术。中位随访8.5年(1-20年)期间无宫颈癌相关死亡,发现1例复发;LLETZ组记录17次妊娠、17个活产儿,无第二孕期流产,1例36周早产。

要点

  • 小体积IB1期宫颈癌保守手术后中位随访8.5年无宫颈癌相关死亡,仅1例复发。
  • LLETZ组17次妊娠均获活产,无第二孕期流产,仅1例36周早产。
  • 95%(111/117)患者行双侧盆腔淋巴结切除术,仅1例淋巴结阳性。

核心结论

  • 对小体积IB1期宫颈癌行非根治性手术加盆腔淋巴结切除阴性可确保极好生存且不损害产科结局;若正在进行的前瞻性研究验证这些结果,这些患者或可避免根治性手术。

研究设计与样本

  • 纳入2000年12月至2021年12月在北方妇科肿瘤中心治疗的所有FIGO IB1期、环切标本估计肿瘤体积<500 mm3的宫颈癌患者,共117例。
  • 58例(49.5%)行LLETZ保留生育功能保守治疗,59例(50.5%)行单纯子宫切除术。
  • 收集临床病理与人口学数据,并结合初级保健和死亡登记进行详细随访及产科结局记录。

主要发现

  • 95%(111/117)患者行双侧盆腔淋巴结切除术,其中1例淋巴结阳性。
  • 中位随访8.5年(1-20年)期间无宫颈癌相关死亡,发现1例复发。
  • LLETZ组记录17次妊娠,出生17个活产儿;无第二孕期流产,1例36周早产。

临床怎么用

  • 作者认为,若正在进行的前瞻性研究验证这些结果,这些患者或可避免根治性手术。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Standard surgical treatment of FIGO stage 1B1 cervical cancer is open radical surgery. However, there is increasing evidence that for small tumours a more conservative approach can minimise fertility consequences without impacting on long term oncologic outcomes. The objective of our study is to present survival and obstetric outcomes following extended follow-up for patients who underwent conservative management of small-volume stage 1B1 disease. METHODS: All patients with FIGO stage 1B1 cancer and estimated tumour volume of <500 mm3 in a loop biopsy specimen treated in Northern Gynaecological Oncology Centre between December 2000 and December 2021, were included in the study. Clinico-pathological and demographic data were collated alongside detailed follow-up and obstetric outcomes in conjunction with primary care and death register. RESULTS: 117 patients underwent conservative surgery for small volume stage 1B1 disease. 58 (49.5%) underwent fertility sparing conservative management with LLETZ while 59 (50.5%) underwent simple hysterectomy. Overall, 95% (111/117) of the patients underwent bilateral pelvic lymphadenectomy and 1 positive node was identified. There was no death related to cervical cancer and 1 recurrence identified during a median follow up of 8.5 years (1-20). 17 pregnancies have been recorded in patients underwent LLETZ and 17 live babies were born. No second trimester miscarriages were noted and there was one preterm delivery (36 weeks). CONCLUSION: Non-radical surgery with negative pelvic lymphadenectomy for smallvolume stage 1B1 cervical cancer ensures excellent survival without compromising obstetric outcomes. Should these results be verified by the ongoing prospective studies, radical surgery for these patients may be avoided.

来源:Gynecol Oncol,查看原文。版权归原作者所有。

引用

  1. Korompelis P, Rundle S, Cassar V, et al. Conservative surgical approaches for small volume FIGO stage IB1 cervical cancer. Updated survival and obstetric outcomes of an expanded cohort. Gynecol Oncol. 2023. PMID: 37542842. doi:10.1016/j.ygyno.2023.07.018

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。